Radionetics Oncology

Radionetics Oncology is a clinical-stage biotechnology company focused on discovering and developing novel small molecule radiopharmaceuticals for the treatment of various cancers. Their innovative approach utilizes G protein-coupled receptors (GPCRs) as targets for radiopharmaceuticals, a largely unexplored area. Radionetics leverages its expertise in drug discovery and development to create targeted therapies that deliver radiation directly to tumors, offering the potential for more effective and less toxic treatments for patients.

The company has a strong team of experts in GPCR discovery, oncology drug development, and radiopharmaceutical manufacturing. Radionetics has a robust pipeline of novel radioligands targeting GPCRs for the treatment of a broad range of cancers, including breast cancer and lung cancer. They are committed to rapidly advancing their programs towards clinical development and bringing much-needed new therapies to patients.

Radionetics offers a hybrid work model, allowing employees to work from both the office and remotely. The company is headquartered in San Diego, California, in the heart of the thriving life sciences community.

Radionetics offers a competitive compensation package, including bonus opportunities, equity, comprehensive health insurance coverage (medical, dental, vision), life and accidental death and dismemberment (AD&D) insurance, short-term and long-term disability insurance, a 401(k) retirement plan, four weeks of paid time off annually, and generous paid holidays.

Radionetics Oncology is a clinical-stage company focused on the discovery and development of novel radiopharmaceuticals for the treatment of a wide range of oncology indications. The company leverages a unique platform that combines the power of radiopharmaceuticals with the precision of small molecule targeting to novel GPCRs. Radionetics is advancing a pipeline of novel small molecule radioligands targeting GPCRs for the treatment of a broad range of cancers, including breast cancer, lung cancer, and other indications of high unmet need. The company believes that by developing these targeted therapies, they can bring the power of precision radiopharmaceuticals into a new era and provide effective new treatments for cancer patients.

Radionetics Oncology fosters a highly collaborative and dynamic culture, driven by a shared passion for improving the lives of cancer patients. Their team is comprised of talented individuals who are experts in their respective fields and united by a strong sense of purpose and urgency to discover new and innovative cancer treatment options. They emphasize a collaborative and supportive work environment, recognizing the importance of teamwork in advancing cutting-edge research and bringing life-saving therapies to the clinic.

Radionetics Oncology is committed to fostering a diverse and inclusive workplace. They believe that a diverse workforce drives success and is proud to provide qualified applicants with equal consideration for employment, regardless of race, color, creed, national origin, ancestry, religion, sex, pregnancy, marital status, sexual orientation, gender, gender identity and expression, age, physical or medical disability, medical condition, genetic information, disability or protected veteran status or disability, or any other protected status designated by federal, state, or local law. They also encourage individuals with disabilities to contact them for any necessary accommodations to access employment opportunities.